Slocum, Gordon & Co’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-17
Closed -$6.33K 140
2025
Q1
$6.33K Buy
+17
New +$6.47K ﹤0.01% 117
2024
Q4
Sell
-17
Closed -$6.14K 141
2024
Q3
$6.14K Sell
17
-57
-77% -$19.7K ﹤0.01% 118
2024
Q2
$25.2K Hold
74
0.02% 101
2024
Q1
$26.5K Hold
74
0.02% 97
2023
Q4
$22.2K Hold
74
0.02% 100
2023
Q3
$20.2K Hold
74
0.02% 103
2023
Q2
$22.6K Buy
74
+57
+335% +$16.5K 0.02% 98
2023
Q1
$4.85K Hold
17
﹤0.01% 122
2022
Q4
$4.16K Buy
+17
New +$3.86K ﹤0.01% 121

Other funds holding SYK

Slocum, Gordon & Co's SYK Position: Q2 2025 in Review

Slocum, Gordon & Co sold out of Stryker (SYK) in Q2 2025, closing a stake of 17 shares — an estimated $6.33K sold.

Slocum, Gordon & Co first reported a position in SYK in Q4 2022 and held it in 9 quarters. The position peaked at $26.5K in Q1 2024. 2,254 funds tracked by Wall St. Rank hold SYK as of Q2 2025.

  • Slocum, Gordon & Co reported no remaining Stryker position as of Q2 2025 after selling out during the quarter.
  • Slocum, Gordon & Co sold 17 Stryker shares in Q2 2025, an estimated $6.33K.
  • Slocum, Gordon & Co first reported a position in Stryker in Q4 2022 and held it in 9 quarters.
  • Slocum, Gordon & Co's Stryker position peaked at $26.5K in Q1 2024.
  • 2,254 funds tracked by Wall St. Rank held Stryker as of Q2 2025.

Based on Slocum, Gordon & Co's 13F filing for Q2 2025, filed 19 Aug 2025.